Molbio Diagnostics IPO Subscription History

As of August 12, 2026, the Molbio Diagnostics IPO has been subscribed 70.27 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest.

The Molbio Diagnostics IPO subscription window was open from August 10, 2026 to August 12, 2026. Investors could apply through their demat account or ASBA facility.

The Molbio Diagnostics IPO has a price band of ₹768 to ₹807 per share, with a lot size of 18 shares. Minimum retail investment: ₹13,824 (lower band) or ₹14,526 (upper band).

The QIB category has been subscribed 186.39 times. QIBs were offered 2,325,146 shares. Strong QIB subscription indicates high institutional confidence.

Retail investors subscribed 12.97 times. Retail was offered 4,069,004 shares. High retail subscription reflects strong small-investor interest.

Overall NII: 49.80×. bNII (>₹10L): 50.82×, sNII (<₹10L): 47.76×. NII includes HNIs and corporate entities investing above ₹2 lakh.

Basis of allotment is on August 13, 2026. Check via the registrar's website, KFin Technologies Limited using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.

Molbio Diagnostics IPO is expected to list on August 17, 2026. Shares will list on NSE,BSE. Allotted shares are credited to your demat account 1 business day before listing.

A subscription multiple of 70.27× means investors have bid for 70.27 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.

Based on the current retail subscription of 12.97×, the estimated allotment probability for retail investors is Low–Moderate. Lottery-based allotment. Retail allotment in oversubscribed IPOs is done by computerised lottery, each valid application has an equal probability regardless of the number of lots applied for.

You can apply for Molbio Diagnostics IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Aug 10 to Aug 12, 2026.

The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Molbio Diagnostics IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.